Browsing "Pathology" by Keyword : Survival Analysis
Showing results 14 to 22 of 22
| Pub Year | | Title | Author(s) |
| 2013 | | Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer. | 김도윤, 김영배, 서광욱, 오승엽 |
| 2014 | | Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. | 김도윤, 김영배, 서광욱, 오승엽, 이제희 |
| 2015 | | Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients. | 고영화 |
| 2013 | | Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. | 이다근 |
| 2016 | | Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma | 고영화 |
| 2015 | | Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria. | 공태욱, 백지흠, 유희석, 이용희, 장석준, 전미선 |
| 2022 | | Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined with Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma | 노진, 박준성, 정성현, 최윤석 |
| 2005 | | Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. | 유희석, 이정필, 장기홍, 한재호 |
| 2005 | | Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer. | 김영배, 서광욱 |
1
